Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p

by Cao, J., Cheng, H., Hu, X., Jin, Y.
Published 2021

Is it liver or lung cancer? An intriguing case of lung adenocarcinoma with hepatoid differentiation

by Bakar, N.S, Eezamuddeen, M.N, Esa, N.Y.M, Hamdan, M.F, Zamrud, R.
Published 2018

Low expression of tRF-Pro-CGG predicts poor prognosis in pancreatic ductal adenocarcinoma

by Chen, S., Gao, P., Gao, Y., Jiang, Z., Jin, L., Li, J., Ma, L., Sui, S., Yin, X., Zhu, B., Zhu, C.
Published 2021

NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantita...

by Han, Q., Huang, W., Jiang, Z., Liu, L., Liu, S., Qin, J., Xiao, Y., Xie, J.
Published 2021

N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment

by Guo, M., Li, Z., Ming, L., Qin, Z., Wan, J., Wang, Y., Yang, Z., Zhao, Z., Zheng, J.
Published 2021

Guanylate-binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients

by Gao, F., Li, L., Qu, J., Wan, Q.
Published 2021

miR-423-3p activates FAK signaling pathway to drive EMT process and tumor growth in lung adenocarcinoma through targeting CYBRD1

by Bai, X., Feng, Y., Huang, W., Ma, J., Qi, Q., Sun, X., Wang, C., Zhang, L., Zhang, Q., Zhu, C.
Published 2021

Large-Volume Hyperthermia for Safe and Cost-Effective Targeted Drug Delivery Using a Clinical Ultrasound-Guided Focused Ultrasound Device

by Carlisle, R., Coussios, C.C, Cranston, D., Gleeson, F.V, Gray, M., Lyon, P.C, Mannaris, C., Wu, F.
Published 2021

Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients

by Abd Hamid, U.M, Abrahams, J.L, Duffy, M.J, Evoy, D., McDermott, E.W, Pierce, A., Rudd, P.M, Saldova, R.

Dysregulated ferroptosis-related genes indicate potential clinical benefits for anti–PD-1/PD-L1 immunotherapy in lung adenocarcinoma

by Chen, Y., Li, T., Zhang, X., Zhou, M.
Published 2021

miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—archival samples study

by Garbicz, F., Gondek, A., Grzywa, T.M, Klicka, K., Marczewska, J.M, Paskal, W., Pełka, K., Szczepaniak, K., Włodarski, P.K
Published 2021

Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease

by Feng, Q., Liu, L., Lv, F., Yang, X.
Published 2021

Pectin matrix as oral drug delivery vehicle for colon cancer treatment

by Colombo, G., Sonvico, F., Wong, T.W

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

by Bachier, C., Bai, J., Batrakou, D., Blumenschein, G.R, Broad, R., Devarakonda, S., Doger de Spéville, B., Edelman, M.J, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gainor, J., Gerry, A., Govindan, R., Heymach, J.V, Holdich, T., Hyland, N., Johnson, M., Lam, V.K, Marks, D., Moreno, V., Navenot, J.-M, Norry, E., Olszanski, A.J, Pentony, M.M, Sanderson, J.P, Wolchinsky, Z.
Published 2022